2h
MyChesCo on MSNTraws Pharma Reports 2024 Financial Results and Advances Bird Flu and COVID ProgramsTraws Pharma, Inc. (NASDAQ: TRAW) has released its financial results for the year ending December 31, 2024, alongside ...
Analysis - More than five years since COVID was declared a pandemic, we're still facing the regular emergence of new variants ...
Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...
A large study found pregnant women infected with SARS-CoV-2 had a lower incidence of Long COVID compared to non-pregnant ...
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
Since 1959 the avian flu virus H5N1 has been popping up around the globe. Now scientists believe it could spark the next ...
Federal cuts pull $200M from health grants, impacting public health preparedness and care in Colorado. State and local ...
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
There is an emerging but erroneous theory that diversity, equity, and inclusion (DEI) initiatives are at odds with the ...
We are delighted by Ajay’s return to the Board of Invivyd as the company prepares to take the next step forward in scaling the medical benefit from its core technologies. Invivyd has rapidly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results